Aegerion Pharmaceuticals Announces First Quarter 2016 Financial Results
May 16, 2016 16:05 ET
|
Aegerion Pharmaceuticals, Inc.
Company records $35.7 million in total net product sales Company now expects full-year revenues for JUXTAPID to be between $90 million and $100 millionCompany continues to...
Aegerion Pharmaceuticals Announces Preliminary Agreements in Principle With DOJ and SEC Related to Ongoing Investigations
May 12, 2016 08:15 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (“Aegerion” or the “Company”) (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and...
Aegerion Pharmaceuticals to Announce First Quarter 2016 Financial Results on Monday, May 16
May 11, 2016 08:05 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 11, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
May 06, 2016 08:10 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 06, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program
April 11, 2016 16:15 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 11, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...
Aegerion Pharmaceuticals Observes World Lipodystrophy Day
March 31, 2016 08:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, MA, March 31, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to...
Aegerion Pharmaceuticals celebra el Día Mundial de las Lipodistrofias
March 31, 2016 07:27 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), una compañía biofarmacéutica dedicada al desarrollo y a la comercialización de terapias...
A Aegerion Pharmaceuticals participa do Dia Mundial da Lipodistrofia
March 31, 2016 07:27 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- A Aegerion Pharmaceuticals, Inc.(NASDAQ:AEGR), uma empresa biofarmacêutica com foco no desenvolvimento e na comercialização de novos produtos...
Aegerion Pharmaceuticals Observes World Lipodystrophy Day
March 31, 2016 07:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company focused on the development and commercialization of novel therapeutics...
Aegerion Pharmaceuticals Observes World Lipodystrophy Day
March 31, 2016 03:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 31, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company focused on the development and commercialization of novel therapeutics...